Fig. 1From: Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challengesGlobal deaths (D) and prevalence (P) for Alzheimer’s disease and other dementias in 2016. Data are n (95% UI). UI = uncertainty interval. Data extracted from the Global Burden of Disease Study of Alzheimer’s disease and other dementias 2016 [1]Back to article page